Newest Progress in Inflammatory Bowel Diseases Treatments Announced at the Crohn's & Colitis Foundation of America's 2015 Advances in IBD Conference
NEW YORK, June 15, 2015 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) and Imedex are pleased to announce that registration is now open for the 2015 Advances in Inflammatory Bowel Diseases Clinical and Research Conference, taking place in Orlando, Florida on December 10-12, 2015. You can register at: http://bit.ly/1o4nrmx.
With 1.6 million Americans suffering from IBD, it is critical that healthcare professionals and researchers come together in an effort to focus on the latest treatments and eventual cures. The conference offers workshops and trainings for clinicians, researchers, allied health professionals, nurses, gastroenterologists and pediatric gastroenterologists. Nearly 60 expert specialists from the US and abroad will lead the sessions.
"As the rate of people with IBD increases worldwide, we are keeping up with the increasing needs that healthcare providers have," said conference Co-chair, Dr. Richard MacDermott, MD. "Our 2 ½ day meeting in December will cover all of the important approaches to both the basic and the advanced care of the IBD patient, as well as recent advances in cutting edge clinical research."
This conference is endorsed by American College of Gastroenterology (ACG), American Gastroenterological Association (AGA) and the British Society of Gastroenterology (BSG), and organized by Imedex, LLC and sponsored through the UAMS College of Medicine Continuing Medical Education to provide continuing medical education for physicians. This continuing nursing education activity has been submitted for approval to the Society of Gastroenterology Nurses and Associates, Inc., an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
About the Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation of America (CCFA) is the largest voluntary non-profit health organization dedicated to finding cures for Inflammatory Bowel Diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit http://www.ccfa.org, call 888-694-8872, and find us on Facebook, Twitter, Instagram, and YouTube.
About Imedex®
Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 100,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, education is the best medicine. ®
Photo - http://photos.prnewswire.com/prnh/20150615/223155
Photo - http://photos.prnewswire.com/prnh/20150615/223154
SOURCE Crohn's & Colitis Foundation of America
Share this article